The rapid emergence of several variants of concern of SARS-CoV-2 calls for evaluations of viral fitness and pathogenicity in animal models in order to understand the mechanism of enhanced transmission and the possible increases in morbidity and mortality rates. Here, we demonstrated that immunity naturally acquired through a prior infection with the first-wave variant does confer nearly complete protection against the B.1.1.7 variant in Syrian hamsters upon reexposure
[[abstract]]BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coro...
Several animal models have been developed to study the pathophysiology of SARS-CoV-2 infection and t...
The global pandemic of coronavirus disease (COVID-19) caused by infection with severe acute respirat...
As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause severe...
Prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides protectiv...
Reinfections with SARS-CoV-2 have already been documented in humans, although its real incidence is ...
B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage ...
Safe and effective vaccines are urgently needed to stop the pandemic caused by severe acute respirat...
Safe and effective vaccines are urgently needed to stop the pandemic caused by severe acute respirat...
The ongoing SARS-CoV-2 epidemic was marked by the repeated emergence and replacement of “variants” w...
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the im...
Small animal models are needed in order to evaluate the efficacy of candidate vaccines and antiviral...
Previously we have shown that a single dose of recombinant adenovirus serotype 26 (Ad26) vaccine exp...
The Omicron BA.1 (B.1.1.529) SARS-CoV-2 variant is characterized by a high number of mutations in th...
AbstractSeveral small animal models have been developed for the study of severe acute respiratory sy...
[[abstract]]BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coro...
Several animal models have been developed to study the pathophysiology of SARS-CoV-2 infection and t...
The global pandemic of coronavirus disease (COVID-19) caused by infection with severe acute respirat...
As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause severe...
Prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides protectiv...
Reinfections with SARS-CoV-2 have already been documented in humans, although its real incidence is ...
B.1.617 is becoming a dominant Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) lineage ...
Safe and effective vaccines are urgently needed to stop the pandemic caused by severe acute respirat...
Safe and effective vaccines are urgently needed to stop the pandemic caused by severe acute respirat...
The ongoing SARS-CoV-2 epidemic was marked by the repeated emergence and replacement of “variants” w...
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the im...
Small animal models are needed in order to evaluate the efficacy of candidate vaccines and antiviral...
Previously we have shown that a single dose of recombinant adenovirus serotype 26 (Ad26) vaccine exp...
The Omicron BA.1 (B.1.1.529) SARS-CoV-2 variant is characterized by a high number of mutations in th...
AbstractSeveral small animal models have been developed for the study of severe acute respiratory sy...
[[abstract]]BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coro...
Several animal models have been developed to study the pathophysiology of SARS-CoV-2 infection and t...
The global pandemic of coronavirus disease (COVID-19) caused by infection with severe acute respirat...